BYOMass Company

BYOMass is developing therapeutics to modulate the central control of metabolism associated with aging and age-related chronic illnesses.

Investors

Technology: Geroscience
Industry: Biotechnology
Headquarters: Sudbury, Massachusetts, United States
Founded Date: 2017
Employees Number: 1-10
Investors Number: 1
Total Funding: 1500000
Last Funding Date: 2019
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership